• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外实验中SARS-CoV-2和流感病毒对细胞因子谱的影响差异

Differentiation of the Cytokine Profile Modified by SARS-CoV-2 and Influenza Virus in an In Vitro Experiment.

作者信息

Zaitseva N V, Starkova K G, Dolgikh O V, Alekseev V B

机构信息

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Perm, Russia.

出版信息

Bull Exp Biol Med. 2025 May;179(1):54-57. doi: 10.1007/s10517-025-06430-x. Epub 2025 Jul 18.

DOI:10.1007/s10517-025-06430-x
PMID:40679527
Abstract

We compared changes in the expression of the cytokine profile modified by SARS-CoV-2 and influenza virus in an in vitro experiment. A mixed population of immunocytes (T-helpers, B cells, NK cells, cytotoxic T lymphocytes, and monocytes) was isolated from peripheral venous blood samples (n = 32) of conditionally healthy male donors aged 25-35 years. The modifying factors were recombinant adenovirus particles of 26 and 5 serotypes containing the gene encoding S protein of SARS-CoV-2, as well as vaccine antigens (hemagglutinins) of influenza virus type A (H1N1 and H2N3) and type B. Multidirectional changes in the cytokine production was revealed upon exposure to SARS-CoV-2 antigens: stimulation of the expression of IL-1β and IL-8 and suppression of the production of IL-4 and IL-6; changes in the expression of IL-8 and IL-6 were more pronounced after combined exposure (SARS-CoV-2 + influenza virus). Influenza virus antigens predominantly stimulated the expression (IL-8), while the maximum cytokine-producing effects were noted after combined exposure to SARS-CoV-2 and influenza virus antigens. The obtained results extend the understanding of the pathogenic mechanisms associated with persistence of SARS-CoV-2 and influenza virus. The modifications of the cytokine profile produced by the viruses and verified in vitro allow predicting and monitoring the course of diseases.

摘要

我们在体外实验中比较了由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和流感病毒引起的细胞因子谱表达变化。从25至35岁的健康男性供体的外周静脉血样本(n = 32)中分离出免疫细胞混合群体(辅助性T细胞、B细胞、自然杀伤细胞、细胞毒性T淋巴细胞和单核细胞)。修饰因子为含有SARS-CoV-2 S蛋白编码基因的26型和5型重组腺病毒颗粒,以及甲型流感病毒(H1N1和H2N3)和乙型流感病毒的疫苗抗原(血凝素)。暴露于SARS-CoV-2抗原后发现细胞因子产生的多向变化:刺激白细胞介素-1β(IL-1β)和白细胞介素-8(IL-8)的表达,并抑制IL-4和IL-6的产生;联合暴露(SARS-CoV-2 + 流感病毒)后,IL-8和IL-6的表达变化更明显。流感病毒抗原主要刺激IL-8的表达,而在联合暴露于SARS-CoV-2和流感病毒抗原后观察到最大的细胞因子产生效应。所获得的结果扩展了对与SARS-CoV-2和流感病毒持续存在相关的致病机制的理解。病毒产生并在体外验证的细胞因子谱修饰有助于预测和监测疾病进程。

相似文献

1
Differentiation of the Cytokine Profile Modified by SARS-CoV-2 and Influenza Virus in an In Vitro Experiment.体外实验中SARS-CoV-2和流感病毒对细胞因子谱的影响差异
Bull Exp Biol Med. 2025 May;179(1):54-57. doi: 10.1007/s10517-025-06430-x. Epub 2025 Jul 18.
2
Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2.旁观者单核细胞驱动 SARS-CoV-2 感染非依赖性 NLRP3 炎症小体反应。
mBio. 2024 Oct 16;15(10):e0081024. doi: 10.1128/mbio.00810-24. Epub 2024 Sep 6.
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
Binding antibody titers against the hemagglutinin and neuraminidase correlate with protection against medically attended influenza A and B disease.针对血凝素和神经氨酸酶的结合抗体滴度与预防甲型和乙型流感就医疾病的保护作用相关。
J Virol. 2025 Jun 17;99(6):e0039125. doi: 10.1128/jvi.00391-25. Epub 2025 May 13.
5
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm).使用紫光蓝光(405纳米)分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的灭活机制。
Appl Environ Microbiol. 2025 Jun 18;91(6):e0040325. doi: 10.1128/aem.00403-25. Epub 2025 May 14.
6
Presence of SARS-CoV-2-specific T cells before vaccination in the Mexican population.墨西哥人群在接种疫苗前存在新冠病毒特异性T细胞。
J Leukoc Biol. 2024 Jun 28;116(1):95-102. doi: 10.1093/jleuko/qiae111.
7
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
8
The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination.新冠疫苗接种后,加强针剂量对泰国医护人员特定B淋巴细胞和T淋巴细胞动态变化的影响
Sci Rep. 2025 Jul 16;15(1):25713. doi: 10.1038/s41598-025-10400-8.
9
Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.在整个 COVID-19 大流行期间健康献血者的抗 SARS-CoV-2 总免疫球蛋白和中和抗体反应:一项纵向观察研究。
Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408.
10
A Plant-Based Dietary Supplement Exhibits Significant Effects on Markers of Oxidative Stress, Inflammation, and Immune Response in Subjects Recovering from Respiratory Viral Infection: A Randomized, Double-Blind Clinical Study Using Vitamin C as a Positive Control.一种植物性膳食补充剂对呼吸道病毒感染康复期受试者的氧化应激、炎症和免疫反应标志物具有显著影响:一项以维生素C作为阳性对照的随机双盲临床研究。
Int J Mol Sci. 2025 May 29;26(11):5209. doi: 10.3390/ijms26115209.

本文引用的文献

1
A systematic review of the clinical characteristics of influenza-COVID-19 co-infection.一项关于流感-COVID-19 合并感染的临床特征的系统回顾。
Clin Exp Med. 2023 Nov;23(7):3265-3275. doi: 10.1007/s10238-023-01116-y. Epub 2023 Jun 16.
2
Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza.比较 COVID-19 和大流行性流感的细胞因子风暴。
J Interferon Cytokine Res. 2022 Aug;42(8):369-392. doi: 10.1089/jir.2022.0029. Epub 2022 Jun 7.
3
Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 和流感感染的细胞因子特征差异突出了其发病机制的关键差异。
Clin Infect Dis. 2022 Jan 29;74(2):254-262. doi: 10.1093/cid/ciab376.
4
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence.COVID-19 的流行病学、发病机制、临床特征、诊断和治疗:当前证据的综述。
Expert Rev Clin Pharmacol. 2021 May;14(5):601-621. doi: 10.1080/17512433.2021.1902303. Epub 2021 May 3.
5
Co-infection of influenza A virus and SARS-CoV-2: A retrospective cohort study.甲型流感病毒和严重急性呼吸综合征冠状病毒 2 型合并感染:一项回顾性队列研究。
J Med Virol. 2021 May;93(5):2947-2954. doi: 10.1002/jmv.26817. Epub 2021 Jan 27.
6
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.新型冠状病毒肺炎与流感的免疫病理学相似性:探讨合并感染的后果。
Microb Pathog. 2021 Mar;152:104554. doi: 10.1016/j.micpath.2020.104554. Epub 2020 Nov 3.
7
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.严重的免疫抑制,而非细胞因子风暴,是 COVID-19 感染的特征。
JCI Insight. 2020 Sep 3;5(17):140329. doi: 10.1172/jci.insight.140329.
8
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.